Watertown Bio Summer Break Quick Hits
Catching up on the latest news as things slow down for the summer.
Advertisement
705 Mount Auburn offers both built out and shell lab space options along with a best-in-class onsite amenity package.
Summer shut downs are in full swing across the life science community, resulting in a lighter newsletter. We will be taking our own break in August, so there won’t be a newsletter the week of August 3rd. Before reading on, consider sharing this newsletter with a friend and subscribe to support our work.
Quick Hits
Business
The US Attorney’s Office for the District of Massachusetts announced that Eyepoint Inc, headquartered at the Riverworks building, has agreed to pay roughly $4.67 million to resolve allegations that it had paid kickbacks to ambulatory surgery centers to purchase its drug DEXYCU, which the government alleges violated the Anti-Kickback Statute and the False Claims Act. Read the full announcement in Watertown News.
Arrivals
Resonance Life Sciences moved into Cambridge Scientific. The company is researching the gut microbiome to develop medical food-type products for patients with autoimmune and inflammatory diseases
DPBIO also moved into Cambridge Scientific. The company specializes in microfluidic laboratory equipment that screens and sort single cells
E&M Biolab also moved into Cambridge Scientific. The company is developing novel bioscaffolds for tissue regeneration.
Pre-Clinical and Clinical Trial News
Diagonal Therapeutics (Arsenal Yards) announced the dosing of the first patient in their Phase 1/2 DIAMOND clinical trial of their lead compound DIAG723 for patients with Hereditary hemorrhagic Telangiectaia (HHT). HHT is a rare blood disorder characterized by abnormal blood vessels that easily bleed, leading to chronic anemia, as well as the formation of abnormal vasculature in the lungs and liver that can cause life threatening complications if they rupture. Diagonal’s Arsenal Street neighbor Tectonic Therapeutic launched a Phase 1 Trial for their HHT therapeutic TX2100 in Q1 of this year.
Ampersand Biosciences (99 Coolidge Ave) announced a target discovery collaboration with Eli Lilly’s Tunelab.
People
Entact Bio announced that Elayne Chan-Enbre joined as SVP of Biological Sciences.
Eyepoint appointed Tarek S. Hassan, M.D., as Chief Strategic Science Officer.
Blogs
Labshares and Landmark Bio both have new blog posts.
That’s all for this week. See you again in August!
23 Elm Street offers 66,634 SF of cutting -edge, fully furnished spec lab space, engineered to support scientific innovations and empower research with best-in-class facilities.
